CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
The APPswe (Swedish) mutation in the amyloid precursor protein (APP) gene causes dominantly inherited Alzheimer’s disease (AD) as a result of increased β-secretase cleavage of the amyloid-β (Aβ) precursor protein. This leads to abnormally high Aβ levels, not only in brain but also in peripheral tiss...
Main Authors: | Bence György, Camilla Lööv, Mikołaj P. Zaborowski, Shuko Takeda, Benjamin P. Kleinstiver, Caitlin Commins, Ksenia Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis, Lars Lannfelt, Casey A. Maguire, J. Keith Joung, Bradley T. Hyman, Xandra O. Breakefield, Martin Ingelsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253118300374 |
Similar Items
-
Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition
by: Chakrabarty Paramita, et al.
Published: (2012-07-01) -
Two C-terminal sequence variations determine differential neurotoxicity between human and mouse α-synuclein
by: Natalie Landeck, et al.
Published: (2020-09-01) -
Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model
by: Kevin Clayton, et al.
Published: (2021-03-01) -
Adhesion molecule L1 binds to amyloid beta and reduces Alzheimer's disease pathology in mice
by: Nevena Djogo, et al.
Published: (2013-08-01) -
Recombinant AAV Gene Therapy and Delivery
by: Carty, Nikisha Christine
Published: (2009)